Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

01-10-2016 | Uitgave 10/2016

Quality of Life Research 10/2016

Assessing health-related quality of life in patients with breast cancer: a systematic and standardized comparison of available instruments using the EMPRO tool

Tijdschrift:
Quality of Life Research > Uitgave 10/2016
Auteurs:
Stefano Maratia, Sergio Cedillo, Javier Rejas
Belangrijke opmerkingen

Electronic supplementary material

The online version of this article (doi:10.​1007/​s11136-016-1284-8) contains supplementary material, which is available to authorized users.
Stefano Maratia and Sergio Cedillo have contributed equally to this work.

Abstract

Purpose

The objective was to obtain a standardized evaluation of available specific and generic breast cancer health-related quality-of-life instruments.

Methods

We carried out systematic literature reviews in the PubMed and EMBASE databases to identify manuscripts which contained information regarding either the development process or metric properties of health-related quality-of-life instruments used among breast cancer patients. Each instrument was evaluated independently by two researchers, and occasionally a third one, using the Evaluating Measures of Patient-Reported Outcomes (EMPRO) tool. An overall score and seven attribute-specific EMPRO scores were calculated (range 0–100, worst to best): concept and measurement model, reliability, validity, responsiveness, interpretability, burden, and alternative forms.

Results

FACT-B was the instrument with the best global performance, obtaining an overall EMPRO score of 79.27. It was also the most accurate instrument on the Concept and Measurement Model, Reliability, and Interpretability attributes. Four more instruments scored over 50 points on the overall score, which summarizes the five attribute-specific scores: EORTC BR-23, IBCSG, WHO-QOL BREF, and SF-36. An overall score of at least 50 points implies that the use of these instruments could be recommended for assessing health-related quality of life in breast cancer patients.

Conclusion

The FACT-B scored the highest on overall on our EMPRO evaluation of instruments measuring health-related quality of life among breast cancer patients. However, depending on the purpose of the study, several instruments (EORTC BR-23, IBCSG, SF-36, and WHO-QOL BREF) have shown good performance in some of the specific individual dimensions included in the EMPRO.

Log in om toegang te krijgen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Podotherapeut Totaal

Binnen de bundel kunt u gebruik maken van boeken, tijdschriften, e-learnings, web-tv's en uitlegvideo's. BSL Podotherapeut Totaal is overal toegankelijk; via uw PC, tablet of smartphone.

Extra materiaal
Supplementary material 1 (DOCX 16 kb)
11136_2016_1284_MOESM1_ESM.docx
Literatuur
Over dit artikel

Andere artikelen Uitgave 10/2016

Quality of Life Research 10/2016 Naar de uitgave